Amblyopia: Recognition, Screening, and Treatment in the Well-Child Care Setting
Listen to this episode
Summary
Amblyopia is by far the most common cause of unilateral vision loss in children, affecting 2 to 4 percent of the population. Screening for amblyopia is an important component of well-child pediatric care. Join Children’s Mercy pediatric ophthalmologist Dr. Atkinson and Transformational Pediatrics, as we discuss the three generally-recognized types of amblyopia, available screening techniques, and treatments of the disease.
First published
09/11/2016
Genres
Parent Podcast
Transformational Pediatrics
View PodcastSimilar Episodes
-
Preventing Type 2 Diabetes
04/22/2020
Dr. Kelsee Halpin discusses Endocrinology and Diabetes.
Clean -
Pediatrics
04/19/2017
info@localgold.com (Dr. Andrew Shepherd, DC)
Learn why a healthy spine can affect the overall health of a child.
Clean -
Amblyopia: Recognition, Screening, and Treatment in the Well-Child Care Setting
09/11/2016
Amblyopia is by far the most common cause of unilateral vision loss in children, affecting 2 to 4 percent of the population. Screening for amblyopia is an important component of well-child pediatric care. Join Children’s Mercy pediatric ophthalmologist Dr. Atkinson and Transformational Pediatrics, as we discuss the three generally-recognized types of amblyopia, available screening techniques, and treatments of the disease.
Clean -
Data Science: Informing Better Health Care Decisions
05/26/2023
Data science -- often discussed with terms like artificial intelligence, machine learning, big data, data goverernance -- has the potential to transform every aspect of health care, from the patient experience to how, when and where care is provided, and improving outcomes. In this Transformational Pediatrics episode, Mark Hoffman, PhD, Chief Research Information Officer at Children's Mercy Kansas City, discusses the challenges and opportunities for data science within pediatric health care and gives examples where it is already making a difference for children today.
Clean
Comments
Sign in to leave a comment.
No comments yet. Be the first to comment!